Franklin Biotechnology Competition

FBDIX Fund  USD 173.05  0.32  0.19%   
Franklin Biotechnology competes with Shelton Green, Dreyfus Natural, Firsthand Alternative, Energy Fund, and Hennessy; as well as few others. The fund is listed under Health category and is part of Franklin Templeton Investments family. Analyzing Franklin Biotechnology competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Franklin Biotechnology to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Franklin Biotechnology Correlation with its peers.

Franklin Biotechnology vs Short Oil Correlation

Excellent diversification

The correlation between Franklin Biotechnology Discove and SNPIX is -0.69 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Biotechnology Discove and SNPIX in the same portfolio, assuming nothing else is changed.

Moving together with Franklin Mutual Fund

  0.86PEYAX Putnam Equity IncomePairCorr
  0.84TEBIX Franklin Mutual BeaconPairCorr
  0.83TEDMX Templeton DevelopingPairCorr
  0.85TEDIX Franklin Mutual GlobalPairCorr
  0.85TEDSX Franklin Mutual GlobalPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
171.57173.67175.77
Details
Intrinsic
Valuation
LowRealHigh
154.39156.49190.36
Details
Naive
Forecast
LowNextHigh
171.36173.46175.55
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
62.27169.61174.97
Details

Franklin Biotechnology Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Franklin Biotechnology and its competitors represents the degree of relationship between the price movements of corresponding funds. A correlation of about +1.0 implies that the price of Franklin and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Franklin Biotechnology does not affect the price movement of the other competitor.

High positive correlations

HNRGXRYEIX
DLDCXNEXTX
HNRGXDLDCX
ALTEXNEXTX
HNRGXNEXTX
ALTEXDLDCX
  

High negative correlations

SNPIXHNRGX
SNPIXRYEIX
SNPIXDLDCX
SNPIXNEXTX
SNPIXALTEX

Risk-Adjusted Indicators

There is a big difference between Franklin Mutual Fund performing well and Franklin Biotechnology Mutual Fund doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Franklin Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Franklin Biotechnology Competitive Analysis

The better you understand Franklin Biotechnology competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Franklin Biotechnology's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Franklin Biotechnology's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
FBDIX NEXTX DLDCX ALTEX RYEIX HNRGX SNPIX
 0.19 
 173.05 
Franklin
 0.50 
 37.52 
Shelton
 0.27 
 51.10 
Dreyfus
 0.94 
 12.86 
Firsthand
 0.72 
 317.93 
ENERGY
 0.28 
 35.75 
Hennessy
 0.47 
 10.61 
Short
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Net Asset
Minimum Initial Investment
Price To Book
Five Year Return
One Year Return
Last Dividend Paid
Price To Earning
Price To Sales
Cash Position Weight
Equity Positions Weight
Three Year Return
Annual Yield
Year To Date Return
Ten Year Return
Day Typical Price
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Franklin Biotechnology Competition Performance Charts

Five steps to successful analysis of Franklin Biotechnology Competition

Franklin Biotechnology's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Franklin Biotechnology in relation to its competition. Franklin Biotechnology's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Franklin Biotechnology in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Franklin Biotechnology's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Franklin Biotechnology, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Franklin Biotechnology position

In addition to having Franklin Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Artificial Intelligence Thematic Idea Now

Artificial Intelligence
Artificial Intelligence Theme
Technology companies, funds, and ETFs across multiple industries that are involved in research or development in the field of reasoning, learning, natural language processing and perception as well as its application to science and commerce. This theme may also include entities involved in cybernetics and cognitive brain simulation field. The Artificial Intelligence theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Artificial Intelligence Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Franklin Mutual Fund

Franklin Biotechnology financial ratios help investors to determine whether Franklin Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Franklin with respect to the benefits of owning Franklin Biotechnology security.
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges